王琦

Cooley advised Gaorong Capital on the oversubscribed closing of its fifth flagship US dollar fund at $1.15 billion, bringing the firm’s assets under management to about $4 billion. Lawyers Jordan Silber, Xun Zeng and Jingyi Xu led the Cooley team advising Gaorong.

Cooley advised Source Code Capital, a leading Chinese venture capital firm, on the closing of its $1 billion fund, which received backing from both new and old investors. Partners Xun Zeng and Jingyi Xu led the Cooley team advising Source Code Capital.

Cooley advised Qiming Venture Partners, a leading venture capital firm in China, on the closing of its oversubscribed Qiming Venture Partners Fund VIII with $2.5 billion in committed capital. Lawyers Jordan Silber, Jingyi Xu, Qi Wang, Sheryl Dai and Hongbo Robert Bao led the Cooley team advising Qiming Venture Partners.

Cooley advised D3 Bio – an emerging global biotechnology company that focuses on discovery, development and registration of innovative cancer drugs – on the close of its $62 million Series A+ financing.